-
Evaluating T-Cell Clonality In Skin Using a Quantitative TRBC1-Clonality Score
Iselin, C., Prompsy, P., Tsai, Y.-C., Bernard, P., André, F., Blanchard, M., Blanchard, G., Roccuzzo, G., Calvão, J., Quaglino, P., Levesque, M., Hötzenecker, W., Chang, Y.-T. & Guenova, E., 13 May 2026, (E-pub ahead of print) In: Journal of investigative dermatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Personalized biologic treatments for patients with Darier disease result in varying responses
Ettinger, M., Burner, T., Lackner, A., Deli, I., Traxler, J., Altrichter, S., Gratz, I. K., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., Mar 2026, In: Journal of the European Academy of Dermatology and Venerology. 40, 3, p. 513-516 4 p.Research output: Contribution to journal › Article › peer-review
-
Real-world evidence on palmoplantar pustulosis: Patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study
Graier, T., Bordag, N., Weger, W., Laschober, N., Ratzinger, G., Jonak, C., Prillinger, K., Müllegger, R., Mlynek, A., Lange-Asschenfeldt, B., Häring, N., Hoetzenecker, W., Posch, C., Ellersdorfer, C., Sator, P., Gruber, B., Hofer, A., Gruber-Wackernagel, A., Legat, F. J. & Großschädl, K. & 8 others, , 06 Jan 2026, In: British Journal of Dermatology. 194, 1, p. 77-85 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T. C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R. & Salzer, H. J. F. & 28 others, , Feb 2025, In: Nature. 638, 8052, p. E46 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
COVID-19 Vaccines: Tolerance of Vaccination in Patients with Allergies
Kogseder, N., Puxkandl, V., Hötzenecker, W. & Altrichter, S., 26 Aug 2025, In: Vaccines. 13, 9, 14 p., 904.Research output: Contribution to journal › Article › peer-review
Open Access
-
IJAMP: A mechanistic study to determine the influence of topical JAK-Inhibitor Ruxolitinib treatment on mastcell function and standard allergy test performance
Hötzenecker, W. (Co-PI), Kimeswenger, S. (Researcher) & Altrichter, S. (PI)
03.07.2025 → 30.04.2027
Project: Clinical studies › Clinical Study (Funded research)
-
Molecular Mechanism of Darier Disease
Kimeswenger, S. (Researcher), Wagner, T. (Researcher) & Hötzenecker, W. (PI)
01.01.2023 → 31.12.2026
Project: Other › Project from scientific scope of research unit
-
Encorafenib + Binimetinib bei Pat. mit lokal fortgeschritt., nicht-resezierbarem oder metastasiertem, BRAFV600-mutiertem Melanom: eine multi-zentrische, multi-nationale, prospektive, nicht-interventionelle Längsschnittstudie in Deutschland und Österreichnterventionelle Längsschnittstudie in Deutschland und Österreich
Fischer, T. (Researcher), Pröll, A. (Researcher), Wahl, G. (Researcher), Öllinger, A. (Researcher) & Hötzenecker, W. (PI)
01.12.2019 → 31.12.2027
Project: Clinical studies › Clinical Study (Industry project)
-
Prospektive Beobachtungsstudie von erwachsenen Patienten, die mit Dupixent gegen atopische Dermatitis behandelt werden.
Angelova-Fischer, I. (Researcher), Pröll, A. (Researcher), Schütz-Bergmayr, M. (Researcher) & Hötzenecker, W. (PI)
01.06.2019 → 31.12.2026
Project: Clinical studies › Clinical Study (Industry project)
-
ORTH3D: Pilotstudie: Erstellen und testen einer digitalisierten 3D gedruckten Orthese zur Skoliosebehandlung
Kimeswenger, S. (Researcher), Hötzenecker, W. (PI) & Puxkandl, V. (Researcher)
01.10.2024 → 30.09.2025
Project: Funded research › FFG - Austrian Research Promotion Agency
-
Labordiagnostik bei Allergien
Hötzenecker, W. (Speaker)
02 Dec 2023Activity: Talk or presentation › Invited talk › science-to-science
-
Hilfe - ich vertrage überhaupt keine Medikamente!
Hötzenecker, W. (Speaker)
05 Nov 2023Activity: Talk or presentation › Invited talk › science-to-science
-
Hilfe - ich vertrage überhaupt keine Medikamente!
Hötzenecker, W. (Speaker)
21 Oct 2023Activity: Talk or presentation › Invited talk › science-to-science
-
Darier Disease
Hötzenecker, W. (Speaker)
11 Oct 2023Activity: Talk or presentation › Invited talk › science-to-science
-
Neues aus der Allergologie
Hötzenecker, W. (Speaker)
28 Sept 2023Activity: Talk or presentation › Invited talk › science-to-science